Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human growth hormone for strength in spinal muscular atrophy type II and III
2005-002822-78Phase 2Completed
- Sponsor
- Klinik für Neuropädiatrie und Muskelkrankheiten
- Start
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of somatropin in spinal muscular atrophy (SMA) (2 arms), sponsored by Klinik für Neuropädiatrie und Muskelkrankheiten. Primary endpoint: Upper extremity muscle strength megascore. Started Nov 2005; status: completed.
02
Drugs
somatropin
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on 2005-002822-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002822-78.